- Q1 2024 Kymera Therapeutics Inc Earnings Call TranscriptMay 02, 2024$36.3 (+0.17%)Earnings
- Q4 2023 Kymera Therapeutics Inc Earnings Call TranscriptFeb 22, 2024$40.49 (+4.71%)Earnings
- Kymera Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Kymera Therapeutics Inc Virtual Immunology R&D Day TranscriptJan 04, 2024
- Kymera Therapeutics Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Kymera Therapeutics Inc Earnings Call TranscriptNov 02, 2023$12.08 (+4.59%)Earnings
- Kymera Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Kymera Therapeutics Inc Earnings Call TranscriptAug 03, 2023$23.88 (+11.07%)Earnings
- Kymera Therapeutics Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Kymera Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Kymera Therapeutics Inc Earnings Call TranscriptMay 04, 2023$26.24 (-15.08%)Earnings
- Q4 2022 Kymera Therapeutics Inc Earnings Call TranscriptFeb 23, 2023$33.16 (+5.17%)Earnings
- Kymera Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Kymera Therapeutics Inc Investor Webcast KT-474 Clinical Update Call TranscriptDec 14, 2022
- Kymera Therapeutics Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Kymera Therapeutics Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- Q3 2022 Kymera Therapeutics Inc Earnings Call TranscriptNov 03, 2022$30.92 (+7.55%)Earnings
- Kymera Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Kymera Therapeutics Inc Earnings Call TranscriptAug 09, 2022$30.35 (-3.44%)Earnings
- Kymera Therapeutics Inc at UBS Global Healthcare Conference TranscriptMay 23, 2022
- Kymera Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 Kymera Therapeutics Inc Earnings Call TranscriptMay 03, 2022$24.88 (-23.98%)Earnings
- Kymera Therapeutics Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 10, 2022
- Kymera Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Kymera Therapeutics Inc To Host Virtual R&D Day TranscriptDec 16, 2021
- Kymera Therapeutics Inc at Evercore ISI HealthCONx Virtual Conference TranscriptDec 01, 2021
- Kymera Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2021
- Kymera Therapeutics Inc To Discuss Data From KT-474 Phase 1 Trial Call TranscriptOct 27, 2021
- Kymera Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Kymera Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Kymera Therapeutics Inc at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Kymera Therapeutics Inc Presenting at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Kymera Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
Kymera Therapeutics Inc To Discuss Data From KT-474 Phase 1 Trial Call Transcript
Good morning. I'd like to welcome everyone to Kymera Therapeutics conference call. (Operator Instructions) The call is being webcast live on the Investor and Media section of Kymera's website at kymeratx.com. This call is the property of Kymera Therapeutics and recording and reproduction or transmission of this call without express written consent of Kymera Therapeutics is strictly prohibited. Please note, the call is being recorded. I would now like to hand the call over to your host today, Bruce Jacobs, Chief Financial Officer. Please begin.
Good morning, everyone, and thank you for joining us today on our call to discuss the new KT-474 Phase I clinical trial data that we released this morning at the TPD Summit. These data are summarized in a press release that we issued this morning.
Additionally, the press release and the presentation slides used on this call can be found on the Investors section of our website at kymeratx.com.
Starting on Slide 2 of the accompanying presentation. During
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)